MYOM2 and neoplasm: Since the above specific situations may exist in clinical practice, such as painful and unbearable biopsy for some patients, non-secretory or hyposecretory M protein, extramedullary infiltration et al., DLCT could be employed to evaluate tumor burden additionally.